Studies by Kyoko Okamura et all (13) confirmed the high diagnostic value of CEA and CYFRA 21–1 tumor markers for differentiating 655 patients with primary LC from 237 COPD patients. Here, CEACAM5 is linked to laryngotracheoesophageal cleft.